PloS one · 2026
Pharmacist-led educational intervention to improve knowledge, medication adherence, and asthma control among asthma patients at Ayder Comprehensive Specialized Hospital: A protocol for randomized controlled trial.
Протокол клинического исследованияСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tekele Mekuriaw Dereje, Kassa Goitom Belay, Welekidane Yainu Welegerima, Berhe Derbew Fikadu, Gebre Abadi Kahsu, Tsadik Afewerki Gebremeskel
Аннотация
OBJECTIVE: To evaluate the effect of a pharmacist‑led educational intervention on medication knowledge, adherence, and asthma control among adult asthma patients at Ayder Comprehensive Specialized Hospital, Ethiopia.
METHODS: A single‑blind, parallel‑group randomized controlled trial will be conducted. All eligible adult asthma patients on active follow‑up at the chest clinic of Ayder Comprehensive Specialized Hospital will be included. Participants will be randomly assigned via a computer‑generated sequence to an intervention group (structured pharmacist‑led education using teach‑back, illustrated pamphlets, a follow‑up phone call and SMS) or a control group (routine care). Outcome assessors will be blinded to group allocation. Outcomes will be measured at baseline and after three months, including medication adherence (GMAS), asthma control (ACT), medication knowledge, correct inhaler technique, and domain‑specific adherence barriers. Data will be analyzed using intention‑to‑treat with multivariable binary logistic regression, chi‑square tests, independent T-test, McNemar test, Mann‑Whitney U test, and Fisher's exact test where appropriate. Subgroup analyses will be performed to explore whether the intervention effect differs across patient characteristics. A p‑value < 0.05 will be considered statistically significant, with 95% confidence intervals reported.
TRIAL REGISTRY: Pan African Clinical Trials Registry (PACTR202508565637179).
METHODS: A single‑blind, parallel‑group randomized controlled trial will be conducted. All eligible adult asthma patients on active follow‑up at the chest clinic of Ayder Comprehensive Specialized Hospital will be included. Participants will be randomly assigned via a computer‑generated sequence to an intervention group (structured pharmacist‑led education using teach‑back, illustrated pamphlets, a follow‑up phone call and SMS) or a control group (routine care). Outcome assessors will be blinded to group allocation. Outcomes will be measured at baseline and after three months, including medication adherence (GMAS), asthma control (ACT), medication knowledge, correct inhaler technique, and domain‑specific adherence barriers. Data will be analyzed using intention‑to‑treat with multivariable binary logistic regression, chi‑square tests, independent T-test, McNemar test, Mann‑Whitney U test, and Fisher's exact test where appropriate. Subgroup analyses will be performed to explore whether the intervention effect differs across patient characteristics. A p‑value < 0.05 will be considered statistically significant, with 95% confidence intervals reported.
TRIAL REGISTRY: Pan African Clinical Trials Registry (PACTR202508565637179).